Actokine Therapeutics

Forma Therapeutics Holdings, Inc is a biopharmaceutical company based in Watertown, MA, specializing in the development of innovative therapies for various disease areas. With a focus on science and technology, they strive to create sustainable business practices while partnering with other organizations. Their commitment to progress is evident through their collective efforts and accountability, as showcased in their R&D pipeline and financial results. Novo Nordisk, a global healthcare company, is actively involved in the acquisition of fill-finish sites and has recently filed their annual report with the SEC. With a significant increase in sales, they continue to make strides in the industry, offering approved medicines for various indications. Novo Nordisk's dedication to patient help, supplier assistance, and ESG reporting is evident through their online presence and global reach.Generated from the website

Seaside Therapeutics, based in Cambridge, is a pioneering leader in rare disease medicine, exemplified by its commitment to advancing the rare disease community. Ultragenyx, a subsidiary of Seaside Therapeutics, is at the forefront of driving progress in the field of rare disease treatment, dedicated to propelling the rare disease community forward. Generated from their website's infomation